Indegene Omnipresence truly applies the power of modern omnichannel technology and advanced capabilities such as machine learning to achieve best-in-class customer-centric experiences,” said Manish Gupta, co-founder and CEO of Indegene.ĭr. This investment will further accelerate the roadmap and deployments of our Customer Experience Management (CXM) platform for life sciences and healthcare clients. “We are excited to welcome Syneos Health as an investor for Indegene’s Omnipresence subsidiary.
Combined with Indegene’s deep industry expertise, analytics, and omnichannel engagement IP, Omnipresence enables life sciences organizations to elevate and transform the experiences they can deliver to healthcare professionals, patients, and business stakeholders. The Omnipresence platform, built as a strategic alliance with Microsoft since 2017, brings together Microsoft Azure analytics as well as Microsoft AI together with Microsoft Dynamics 365 and Power Platform for business applications, and Microsoft Office 365 and Teams for productivity and collaboration. Omnipresence is a next-generation unified customer experience platform for healthcare and life sciences organizations with CRM, omnichannel engagement, advanced analytics, and AI capabilities in a single unified platform. Syneos Health is the only fully integrated biopharmaceutical solutions organization, and provides end-to-end drug development and commercialization solutions to biopharmaceutical customers in more than 110 countries. 9, 2020 /PRNewswire/ - Indegene, a leading Healthcare Tech firm focused on the global life sciences industry, announced Syneos Health (NASDAQ: SYNH) as a strategic collaborator and minority investor in Indegene Omnipresence Inc., a wholly-owned subsidiary of Indegene. “Our joint customers will benefit from a solution built with improved business outcomes in mind,” he added.PRINCETON, New Jersey and BANGALORE, India, Jan. “Together with Microsoft, we are building the new global standard for life sciences commercial clouds,” said Sanjay Virmani, EVP of Indegene. Robust analytics, complete with machine learning, will be built directly into everyday tasks and workflows, creating seamless, data-driven recommendations with predictive and prescriptive insights. Indegene and Microsoft will focus on addressing the specific challenges faced by life science manufacturers. The availability of the solution is expected by July this year, with global deployments to follow. “We are excited to combine Indegene’s Omnipresence solution and extensive life sciences expertise with our Dynamics 365 customer engagement platform,” said Jujhar Singh, Corporate Vice President, Microsoft Dynamics 365. The solution will help simplify digital content development and management as well as provide in-line analytics and optimisation to support the representatives and improve the customer experience. Microsoft “Dynamics 365 for Sales” will combine with the “Indegene Omnipresence” platform to create a modern, mobile and multi-channel customer relationship management (CRM) solution, specifically for sales and medical representatives to better engage healthcare practitioners. Global healthcare solutions provider Indegene and Microsoft on Tuesday joined hands to deliver the next generation of commercial cloud applications to life sciences.
0 kommentar(er)
